Key Takeaways
- EBITDA multiples for U.S. orthodontic practices in 2026 range from 5x–8x for practices under $500K EBITDA up to 12x–18x for practices above $5M. Larger practices often command higher multiples because of scale and stronger buyer competition.
- Practice size, provider diversification, and payer mix can be some of the main factors that move orthodontic practices toward the upper or lower end of their size-band multiple ranges.
- DSO and private equity buyers generally pay higher EBITDA multiples than individual private buyers, although equity and earnout components can change the seller’s final cash proceeds.
- McLerran & Associates’ CPA-led, diligence-grade valuations and competitive bid process can help sellers achieve approximately 30% higher valuations and a high close rate by creating tension among vetted buyers.
- Talk with McLerran & Associates in a free, confidential discovery call to review a side-by-side valuation and see which buyer path may best support your goals.
EBITDA Multiples for Orthodontic Practices in 2026
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. In plain terms, it is the normalized annual profit of the practice after removing the owner’s personal expenses, non-recurring costs, and above-market compensation. This figure tells a buyer how much cash the business actually generates. The multiple reflects how many years of that profit a buyer is willing to pay for today.
The table below presents McLerran & Associates’ observed ranges for U.S. orthodontic practices in 2026, organized by EBITDA size band. These ranges reflect the firm’s transaction data and are consistent with broader industry reporting from sources including CT Acquisitions’ 2026 dental M&A multiple guide and FOCUS Investment Banking specialty reports. All figures are ranges only.
| EBITDA Size Band | Typical Buyer Profile | Observed Multiple Range | Notes |
|---|---|---|---|
| Under $500K | Individual / small DSO add-on | 5x – 8x | Higher provider dependency, SDE basis common for solo practices |
| $500K – $1M | Regional DSO add-on | 6x – 8x | Scale begins to attract institutional interest, payer mix matters |
| $1M – $3M | Regional or national DSO add-on | 7x – 11x | Associate doctors and multi-location presence can push toward upper end |
| $3M – $5M | Strategic acquirer / emerging platform | 9x – 12x | Platform-level buyer competition, management depth critical |
| $5M+ | Private equity platform / recapitalization | 12x – 18x | Multi-state scale, practice may anchor a new DSO platform |
These ranges are consistent with FOCUS Investment Banking’s 2025–2026 specialty dental reporting, which places orthodontic practices at a meaningful premium to general dentistry across all size bands. Orthodontics can command a premium over general dentistry because of elective, cash-pay, and contract-based revenue structures, as noted in CT Acquisitions’ 2026 dental DSO M&A multiples guide.
How Practice Size Shapes Ortho EBITDA Multiples
Scale affects multiples by expanding the buyer universe and by reducing perceived risk. A single-location practice where the owner performs the majority of production is a fundamentally different asset than a three-location group with producing associates and documented systems. Buyers often pay a higher multiple for the latter because the revenue is more likely to transfer after the owner steps back.
Provider dependency, meaning the degree to which a practice’s revenue is tied to one clinician’s chair time, can act as a meaningful valuation discount. Practices where the owner performs a large share of total production are viewed as higher risk, because patient relationships and revenue may not fully transfer after a sale. Adding even one producing associate can move a practice up a meaningful portion of a multiple turn by showing that collections are not person-dependent.
Multi-location scalability introduces a separate premium. Regional clusters of three or more offices with shared management infrastructure can command a platform premium over single-location add-ons, because they offer buyers immediate operating leverage across shared administration, marketing, and supply chain. The largest orthodontic groups, particularly those with $3M or more in EBITDA and genuine management depth, can attract private equity interest as a platform acquisition. In that scenario, the practice becomes the foundation of a new DSO rather than simply an add-on to an existing one.
Owners in the $1M–$3M EBITDA band occupy a particularly important position. They are often large enough to attract institutional DSO buyers but may also be well-suited to a private buyer depending on their goals and market. Understanding which path can produce the better outcome usually requires a side-by-side valuation, which McLerran & Associates delivers as a standard part of every engagement. That choice between buyer types introduces a new set of considerations that can be as consequential as practice size itself.
Request a confidential discovery call with McLerran & Associates to see which size band your practice falls into and what that may mean for your achievable multiple.
Comparing DSO and Private-Buyer Multiples for Orthodontic Practices
Buyer type can be as consequential as practice size in determining the final multiple. DSO and private equity buyers underwrite value on an EBITDA multiple basis and compete for practices that fit their regional density or specialty strategy. Individual private buyers, typically dentists purchasing their first or second practice, often evaluate value differently and may anchor to a percentage of collections or a net cash flow multiple that reflects their personal clinical capacity and replacement salary economics.
The table below compares McLerran & Associates’ observed outcomes across the two buyer types. The firm’s roughly even split between private-buyer and DSO transactions gives it a genuine side-by-side view that single-lane brokers usually cannot replicate.
| Dimension | Private Buyer (Doctor-to-Doctor) | DSO / Private Equity Buyer |
|---|---|---|
| Valuation basis | Percentage of collections or net cash flow multiple | Normalized EBITDA multiple |
| Typical multiple range | Lower, reflects individual buyer’s cash flow needs | Higher, reflects institutional buyer’s platform economics |
| Cash at close | Typically higher percentage of total consideration | Can range widely, up to approximately 40% may be equity or earnout |
| Best fit (practice size) | Practices generally under $1.5M revenue | Practices generally $1.5M+ revenue, strongest above $3M EBITDA |
The DSO path introduces complexity that the headline multiple alone does not capture. As much as 40% of a DSO deal can be paid in equity rather than cash, which means the seller becomes an investor in the acquiring organization. That equity can be held at the joint-venture level, with distributions and a more predictable floor, or at the holding-company level, where the ceiling is higher but distributions are absent and the outcome depends on a future recapitalization event.
McLerran & Associates produces multi-year, multi-structure financial forecasting so owners can compare real after-tax proceeds across deal structures before signing a letter of intent. McLerran’s competitive bid process, typically running approximately 45 to 60 days and generating around 10 offers, creates the tension that can move DSO buyers toward the upper end of their range. Poorly run or undercapitalized DSOs are blacklisted from the process, so the offers that reach the table come from vetted, well-backed buyers with a track record of honoring agreed terms through diligence.
Key Value Drivers That Move Ortho Multiples
Within any size band, individual practices can land at materially different points in the range based on a set of ortho-specific value drivers. Buyers often assess risk first. The multiple can be viewed as a measurement of how confident a buyer is that the practice’s earnings will transfer and persist after the owner exits.
The following factors can push a practice toward the upper end of its size-band range:
- Private-pay and fee-for-service mix. Orthodontic practices with strong private-pay revenue can command higher multiples because buyers often pay premiums for predictable reimbursement and higher margins per chair. Heavy reliance on a single insurance carrier or Medicaid concentration can compress multiples by a meaningful amount.
- Provider diversification. Multi-provider practices can reduce buyer concern over post-sale revenue loss. Practices where the owner produces 70% or more of total collections can face a valuation discount because of high provider concentration risk.
- Hygiene and recall strength. Strong hygiene revenue and recall discipline signal a stable, transferable patient base and recurring revenue. These factors can support premium multiples and stronger DSO offers.
- Documented systems and team stability. High staff turnover or disorganized financials can suppress buyer offers because uncertainty is priced in as risk. Practices with documented workflows, stable teams, and clean financial records can reduce perceived transition risk.
- Growth trajectory. Consistent growth in case starts over a three- to five-year period can produce higher values than flat or declining performance, because buyers are paying for future earnings, not just current ones.
- Modern technology and facility quality. Practices without current digital imaging and intraoral scanners consistently land in the lower half of size-matched ranges. Practices with standardized digital platforms across all locations tend to trade at the top of the multi-site band.
The following risk factors can compress multiples within a band:
- Single-provider dependency with the owner performing the large majority of production
- Heavy Medicaid or HMO concentration, which narrows the buyer universe
- One insurance carrier representing a disproportionate share of collections
- Flat or declining case-start trends over the prior three years
- Unfavorable lease terms or a facility requiring significant capital investment
- Disorganized financials or undocumented add-backs that cannot survive diligence scrutiny
How McLerran & Associates Builds Valuations That Survive Diligence
A valuation only helps when it can hold up after a sophisticated buyer’s team examines it. In 2026, the window from letter of intent to closing in dental transactions is typically around 90 days. During this period, quality-of-earnings reviews, meaning formal reviews where a buyer’s accountants verify the seller’s EBITDA claims, often take place. These reviews have become more confrontational than in prior years, with buyers pushing back on adjustments that might not have been challenged three years ago. A weak valuation analysis can get renegotiated down at the worst possible moment, after the owner has emotionally committed to a deal.
McLerran & Associates builds every engagement on a CPA-led EBITDA analysis completed before the practice goes to market. The firm remotely accesses the practice’s management software, pulls the necessary reports, and cross-references the data against the financials. The team unpacks every discretionary, personal, and non-recurring expense to arrive at true normalized profitability. Every add-back is documented and defensible, not estimated.
When the buyer’s quality-of-earnings team arrives, McLerran defends the EBITDA it underwrote and reminds buyers that other vetted bidders are waiting if they attempt to trade the deal down. This approach is a key reason McLerran’s clients transact at a rate of approximately 85 to 90%, compared to an industry norm closer to 35 to 40%. The valuation typically does not re-trade because the homework was done carefully at the start.
Request a confidential discovery call with McLerran & Associates to see how a diligence-grade valuation can help protect your number through the full transaction process.
Creating Buyer Competition to Protect and Grow Practice Value
Competitive tension can be the single largest determinant of whether an orthodontic practice owner achieves the upper or lower end of a valuation range. A practice owner who negotiates directly with one DSO has limited leverage. A practice owner whose advisor has brought a full slate of vetted, qualified offers to the table negotiates from a fundamentally different position.
McLerran & Associates runs the structured bid process described earlier, soliciting offers from a pre-qualified pool of DSO and private equity buyers. The process narrows from the broad initial offer set to in-person meetings with the top one to three finalists. Buyers who are known for poor post-close environments, undercapitalization, or renegotiating agreed terms are blacklisted and never reach the table.
This competitive approach can help McLerran’s clients receive materially higher valuations than owners who sell on their own. That premium is not accidental. It reflects a competitive process run by advisors who have closed approximately 2,000 transactions and who understand how to control the narrative around a practice’s EBITDA from the first offer through the final closing.
McLerran’s roughly even split between private-buyer and DSO transactions means the firm runs this process on both sides of the market. Owners who are genuinely undecided between paths receive a true side-by-side valuation that quantifies their practice’s worth in both markets, so the decision is made with full information rather than a guess.
Frequently Asked Questions
What is a typical EBITDA multiple for a single-location orthodontic practice in 2026?
A single-location orthodontic practice in 2026 can fall into a wide range depending on its EBITDA size, payer mix, provider structure, and the type of buyer involved. Smaller single-location practices with lower EBITDA and high owner dependency tend to transact at the lower end of the market. Single-location practices with strong private-pay mix, associate doctors, and documented systems can attract institutional DSO interest at meaningfully higher multiples.
No single fixed number applies to every practice. The multiple is determined by the specific financials and by the competitive process used to bring buyers to the table. McLerran & Associates’ CPA-led valuation quantifies where a given practice falls and explains the drivers behind that conclusion.
Do orthodontic practices receive a premium over general dentistry?
Orthodontic practices can command a premium over general dentistry practices of comparable size, and that premium can be meaningful across many size bands. The premium reflects several structural characteristics. Orthodontic revenue often tends to be elective and private-pay, treatment contracts can create recurring cash flow over 18 to 24 months, and the patient base is generally less insurance-dependent than in general dentistry.
These characteristics can reduce buyer risk and support higher multiples. The size of the premium varies by practice profile. A highly owner-dependent single-location orthodontic practice may not command as large a premium as a multi-location group with associate doctors and strong hygiene economics. Specialty alone does not guarantee a premium, and the underlying fundamentals need to support it.
How does McLerran calculate normalized EBITDA for orthodontics?
McLerran & Associates builds its EBITDA analysis from the ground up using a CPA-led methodology. The firm remotely accesses the practice’s management software and financial records, then adjusts reported net income for owner-specific expenses, personal costs run through the business, above-market or below-market owner compensation, non-recurring items, and any deferred maintenance or staffing gaps.
The result is a normalized EBITDA figure that reflects the true economic earnings of the practice as a going concern. This is the number a buyer’s quality-of-earnings team will scrutinize. Because every add-back is documented and defensible before the practice goes to market, McLerran’s valuations tend to hold up through diligence and deals are less likely to be renegotiated down at the closing table.
For orthodontic practices specifically, the analysis also accounts for treatment contract revenue recognition, case-start trends, and payer mix concentration. These factors are ortho-specific and generalist brokers can sometimes handle them incorrectly.
Should I sell to a DSO or a private buyer?
The right path can depend on your practice’s size, profitability, and your personal goals for life after the sale. Smaller premier practices, generally under approximately $1.5M in revenue, often fit a doctor-to-doctor sale where the buyer is another dentist who will carry the practice forward. The largest practices, particularly those with $3M or more in EBITDA, often point toward the DSO or private equity path, where institutional buyers can pay multiples that individual buyers usually cannot match.
Practices in the middle, roughly $1.5M to $3M in revenue, can often go either way. The right answer usually depends on a side-by-side comparison of what each path may net the owner after taxes, deal structure, and time horizon are accounted for. Because McLerran & Associates works both paths in roughly equal measure, it produces that side-by-side analysis as a standard part of every engagement, so owners choose with full information rather than a guess.
Conclusion: Turning Ortho EBITDA Multiples Into a Clear Plan
Current U.S. orthodontic practice EBITDA multiples vary materially by size band and buyer type. The difference between landing at the low end or the high end of a range can represent millions of dollars in proceeds. Practices that achieve the strongest outcomes often share a common thread. They enter the market with a diligence-grade valuation that shapes the narrative around their EBITDA, and they sell through a competitive process that brings multiple qualified buyers to the table at the same time.
McLerran & Associates has spent approximately 35 years building the infrastructure to support that type of outcome. The firm combines a CPA-led valuation that holds up under scrutiny, a vetted buyer pool that spans both the private and DSO markets, and a structured process that creates the competition necessary to protect and grow value. With approximately 2,000 closed transactions, roughly $2 billion in closed transaction volume, and the high close rate noted earlier, the firm’s track record illustrates what a genuine sell-side process can produce versus going it alone.
Orthodontic practice owners who are evaluating options, whether now or in the years ahead, often benefit from first understanding what their practice may be worth in both markets and what a competitive process could realistically produce.
Schedule a free, confidential discovery call with McLerran & Associates to discuss your practice, your goals, and your options. Call (512) 900-7989, email info@dentaltransitions.com, or use the contact form on the firm’s website.
